The good, the bad and the ugly: how altered peptide ligands modulate immunity
about
Stimulation of naive CD8+ T cells by a variant viral epitope induces activation and enhanced apoptosisDesign and Synthesis of Non-Peptide Mimetics Mapping the Immunodominant Myelin Basic Protein (MBP83-96) Epitope to Function as T-Cell Receptor Antagonists.A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responsesActive immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injuryViral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses.West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligandsAn Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT.Improving T cell responses to modified peptides in tumor vaccinesTargeting antigens to dendritic cell receptors for vaccine developmentPeptide Dose and/or Structure in Vaccines as a Determinant of T Cell ResponsesMultiple Sclerosis: Immunopathology and Treatment Update.Formulation and evaluation of poly(lactic-co-glycolic acid) microspheres loaded with an altered collagen type II peptide for the treatment of rheumatoid arthritis.Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis.
P2860
Q30433067-486380F7-ECF6-4DC6-84A1-A434F76F4283Q33838749-5A6963CC-E369-41E4-BABB-38178279DE13Q34004266-FC351157-3CB7-44AA-BD05-1136EE664D89Q34127323-288A8482-A322-4990-9038-5ED781826513Q35121911-C4090372-8CAC-4F2D-A1CE-3EA3F4AEAFA9Q35935892-68466903-E2EE-435D-891E-02801885B810Q36155428-E45D6209-467E-42E8-8E4D-5756FFC22C2AQ37145706-3178B389-4133-4589-A9E0-034FC7DB6B90Q37634253-58A8247F-7404-4D35-ACB2-DB11BD80E8CBQ38162446-A4153872-83C8-4E05-9078-D72F63A02898Q38582086-8E379E23-402E-4FB9-8DC5-7A948992BA3AQ39420793-AF370C29-559C-4194-A4C7-6A1B515A5733Q51841138-03009EA7-5203-47FA-9900-FB86C15DD764Q53163526-B28792E0-EF9C-4DF2-8E70-6B17B179FD75
P2860
The good, the bad and the ugly: how altered peptide ligands modulate immunity
description
im November 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2008
@uk
name
The good, the bad and the ugly: how altered peptide ligands modulate immunity
@en
The good, the bad and the ugly: how altered peptide ligands modulate immunity
@nl
type
label
The good, the bad and the ugly: how altered peptide ligands modulate immunity
@en
The good, the bad and the ugly: how altered peptide ligands modulate immunity
@nl
prefLabel
The good, the bad and the ugly: how altered peptide ligands modulate immunity
@en
The good, the bad and the ugly: how altered peptide ligands modulate immunity
@nl
P2093
P2860
P1476
The good, the bad and the ugly: how altered peptide ligands modulate immunity
@en
P2093
Gabriela Minigo
Magdalena Plebanski
Maria Katsara
P2860
P304
P356
10.1517/14712590802494501
P407
P577
2008-11-06T00:00:00Z